Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Stephanie Deudon"'
Autor:
José Baselga, Alejandro Yovine, Diana Graus Porta, Andrea Kay, Yong Zhang, Michael Shi, Stephanie Deudon, John W. Smith, Hope Rugo, Nicholas Turner, Sara A. Hurvitz, Jose M. Perez-Garcia, Florence Dalenc, Mario Campone, Thomas Bachelot, Fabrice André
Purpose: Fibroblast growth factor receptor 1 (FGFR1) and FGFR2 amplifications are observed in approximately 10% of breast cancers and are related to poor outcomes. We evaluated whether dovitinib (TKI258), an inhibitor of FGFR1, FGFR2, and FGFR3, pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a5f9080cb69d3be9bef60e929cdae9
https://doi.org/10.1158/1078-0432.c.6522158.v1
https://doi.org/10.1158/1078-0432.c.6522158.v1
Autor:
José Baselga, Alejandro Yovine, Diana Graus Porta, Andrea Kay, Yong Zhang, Michael Shi, Stephanie Deudon, John W. Smith, Hope Rugo, Nicholas Turner, Sara A. Hurvitz, Jose M. Perez-Garcia, Florence Dalenc, Mario Campone, Thomas Bachelot, Fabrice André
PDF file - 20K, Dovitinib effectively targets FGFR1 in vivo. FGF23 levels were measured from plasma taken at baseline and during dovitinib treatment in 18, 33, and 20 patients from the FGFR1+/HR+, FGFR1-/HR+, and FGFR1-/HR- patient groups, respective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dfa9045e59c75ec46420f903696c98c
https://doi.org/10.1158/1078-0432.22451300
https://doi.org/10.1158/1078-0432.22451300
Autor:
José Baselga, Alejandro Yovine, Diana Graus Porta, Andrea Kay, Yong Zhang, Michael Shi, Stephanie Deudon, John W. Smith, Hope Rugo, Nicholas Turner, Sara A. Hurvitz, Jose M. Perez-Garcia, Florence Dalenc, Mario Campone, Thomas Bachelot, Fabrice André
PDF file - 61K, Growth Inhibition in FGFR1- and FGFR2-Amplified Cell Lines.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d5be4b46df503ae901d9ead6b868c7c
https://doi.org/10.1158/1078-0432.22451297
https://doi.org/10.1158/1078-0432.22451297
Autor:
Daniel S. Tan, Enriqueta Felip, Gilberto Castro, Benjamin J. Solomon, Alastair Greystoke, Byoungchul Cho, Manuel Cobo, Tae Min Kim, Sandip Ganguly, Enric Carcereny, Luis Paz-Ares, Jaafar Bennouna, Marina Garassino, Michael Schenker, Sang-We Kim, Bijoyesh Mookerje, Vanessa Q. Passos, Stephanie Deudon, Bharani Dharan, Yuanbo Song, Rafael Caparica, Bruce E. Johnson
Publikováno v:
Cancer Research. 82:CT037-CT037
Background: Pembrolizumab improves overall survival (OS) when added to platinum-based doublet chemotherapy (PDC) in patients with aNSCLC. However, progression-free survival (PFS) and OS remain disappointing for most patients and can vary depending on
Autor:
Antonino, Musolino, Mario, Campone, Patrick, Neven, Neelima, Denduluri, Carlos H, Barrios, Javier, Cortes, Kimberly, Blackwell, Hatem, Soliman, Zsuzsanna, Kahan, Hervé, Bonnefoi, Matthew, Squires, Yong, Zhang, Stephanie, Deudon, Michael M, Shi, Fabrice, André
Publikováno v:
Breast Cancer Research : BCR
Background Overexpression of fibroblast growth factor receptor 1 (FGFR1), found in ≤8% of hormone receptor–positive (HR+), human epidermal growth factor receptor 2–negative (HER2−) breast cancer cases, is correlated with decreased overall sur